Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A.
about
Animal models of hemophiliaFVIII inhibitors: pathogenesis and avoidanceRecombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A miceHLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project.A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.Treatment of hemophilia: a review of current advances and ongoing issuesF8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.International workshop on immune tolerance induction: consensus recommendations.Quantitation of anti-factor VIII antibodies in human plasma.Inhibitor development.Genetic aspects and research development in haemostasis.Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.Inhibitors of factor VIII in black patients with hemophiliaNovel drugs to treat hemophilia.Clinical advances in hemophilia management.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?Inhibitors in childhood hemophilia A: genetic and treatment-related risk factors for development and eradication.Inhibitors in haemophilia: what have we learned from registries? A systematic review.Genetic risk factors for inhibitors in haemophilia A.Violating the theory of single gene-single disorder: inhibitor development in hemophiliaThe role of previously untreated patient studies in understanding the development of FVIII inhibitors.The Development of FVIII Inhibitors in Relation to IL10 Gene Polymorphism in Hemophilia A Egyptian Pediatric Patients.A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A PatientsPrevention and prediction of inhibitor risk.The EPIC study: a lesson to learn.The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A.Coagulation deficiencies: a look to the future.Managing haemophilia for life: 4th Haemophilia Global Summit.An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry.Identification and characterization of an adenine to guanine transition within intron 10 of the factor VIII gene as a causative mutation in a patient with mild haemophilia A.In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.Predictive immunogenicity of Refacto AF.A prevalent CTLA4 missense variant significantly associates with inhibitor development in Argentine patients with severe haemophilia A.Improved prediction of inhibitor development in previously untreated patients with severe haemophilia A.Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report.Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.Risk factors associated with inhibitor development in Chinese patients with haemophilia B.
P2860
Q27012571-00FC641F-F441-44C0-92BB-5C74C975A7FBQ27027224-DB0ED820-E883-483E-86FB-AD3C90A7CAB8Q27321626-1CE5431C-31D0-4217-936D-85BAFAC765B1Q33910694-0ECE4409-EC75-4591-96B3-2837DA12040DQ34063824-9B7BACD7-6754-437D-8F4B-6D4A2E6288E7Q35061778-200EBCBA-934A-40E5-BB7F-0301F4509562Q35683781-F63C8535-CF3E-43C7-8F3A-46FC95D215DAQ36463399-F13EA861-4776-46BE-948B-A590553782BDQ36628311-3D41973A-7D0B-41DD-BBF9-75BBC53C5DC7Q36861097-146D18F5-922F-419E-B31E-BBD61BDDB937Q37129689-31A8ECF6-98D3-464D-BB48-E4847BA56679Q37176486-845C7127-D95B-4691-AC44-363258A8C831Q37176521-836F127D-B756-4DA8-A4A8-CDB597571CF8Q37185097-1C72C948-6865-4AC3-9672-6C48C7B88283Q37385316-790EF924-7273-4842-8E68-DFE138EEABD3Q37775029-4A7DCFD9-BD7E-41FB-AA32-0DBA469A3F23Q37900933-E5301EFC-9243-46E6-A932-E4339E0EB13FQ37944291-B24E439A-5416-41A5-B9EF-5B24DA4DDB55Q38056462-C69A750D-5E28-45DD-86A0-231E226A56B9Q38244389-46EB180C-B12A-4F38-ADF6-87DD4BE24B28Q38308196-1BCC30F2-36C0-42E0-8564-456964DEF65DQ38397087-4DD3AF3E-B504-433B-818C-DD2968217628Q38575475-103669B2-92A4-45B8-9D82-AA7242D16050Q38748723-300DA46A-6692-429D-9555-6FB130AD0E11Q38914615-F33EEBF7-E009-41B8-B8C5-6F219B2E875CQ39596266-9EAFB4A9-A07E-436C-B305-11ACC9C5B88AQ41014168-997AA0A9-87C4-4CBE-A86E-87E47858A448Q42211106-E3378969-1339-4827-9E71-841A42AD3322Q43517013-507E758D-0F51-471F-8B76-C0BE12ECBBEBQ44122887-C43BC880-A79E-405F-8821-8E3EFBFABCAEQ44296354-089C3A43-1498-45B7-B06C-1032003CECC5Q44739795-8A0276AD-5A71-44F0-89F7-78F907DAA737Q44846549-5A523E8E-1BC5-46F3-9467-61DA95499F0DQ45857166-86EA93B9-97B9-4C62-92D4-20E46A9F55ADQ45861147-DAC76F1A-0265-4C29-9B66-4EBA216954E2Q45864974-192222B9-9EB7-4699-A169-3D1A845D695FQ45871101-0491A04F-B65C-4E9C-B429-F70522528B79Q45871996-956FE97A-488E-4F9F-8099-20352DAEC52FQ45873690-06907C52-E624-4A17-9A24-18B7AFC7C3FEQ45875494-741BD475-9A40-4A1A-A3F1-0165C7DC1428
P2860
Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Polymorphisms in the CTLA-4 ge ...... ents with severe hemophilia A.
@en
Polymorphisms in the CTLA-4 ge ...... ents with severe hemophilia A.
@nl
type
label
Polymorphisms in the CTLA-4 ge ...... ents with severe hemophilia A.
@en
Polymorphisms in the CTLA-4 ge ...... ents with severe hemophilia A.
@nl
prefLabel
Polymorphisms in the CTLA-4 ge ...... ents with severe hemophilia A.
@en
Polymorphisms in the CTLA-4 ge ...... ents with severe hemophilia A.
@nl
P2093
P1476
Polymorphisms in the CTLA-4 ge ...... ents with severe hemophilia A.
@en
P2093
A-K Lefvert
E Berntorp
J Astermark
J Oldenburg
MIBS Study Group
P304
P356
10.1111/J.1538-7836.2007.02290.X
P577
2007-02-01T00:00:00Z